Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Lyell Immunopharma Inc (LYEL)

Lyell Immunopharma Inc (LYEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Lyell Immunopharma Inc 201 HASKINS WAY SOUTH SAN FRANCISCO CA 94080 USA

www.lyell.com P: 650-695-0677

Description:

Lyell Immunopharma Inc. is a T cell reprogramming company dedicated to the mastery of T cells to cure patients with solid tumors. Lyell Immunopharma Inc. is based in SOUTH SAN FRANCISCO, Calif.

Key Statistics

Overview:

Market Capitalization, $K 647,540
Enterprise Value, $K 501,890
Shares Outstanding, K 254,937
Annual Sales, $ 130 K
Annual Net Income, $ -234,630 K
Last Quarter Sales, $ 10 K
Last Quarter Net Income, $ -52,930 K
EBIT, $ -247,020 K
EBITDA, $ -236,370 K
60-Month Beta -0.54
% of Insider Shareholders 24.00%
% of Institutional Shareholders 66.05%
Float, K 193,752
% Float 76.00%
Short Volume Ratio 0.71

Growth:

1-Year Return 1.41%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.20 on 02/28/24
Latest Earnings Date 05/02/24
Earnings Per Share ttm -0.93
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year -566.67%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

LYEL Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -32.66%
Return-on-Assets % -28.78%
Profit Margin % -180,484.63%
Debt/Equity 0.00
Price/Sales 4,628.09
Price/Cash Flow N/A
Price/Book 0.92
Book Value/Share 2.60
Interest Coverage -2.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar